UK markets open in 3 hours 12 minutes

Merck KGaA (MRKD.XC)

Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
153.480.00 (0.00%)
At close: 04:29PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) 72.69B
Enterprise value 80.16B
Trailing P/E 24.52
Forward P/E 17.27
PEG ratio (5-yr expected) 1.73
Price/sales (ttm)3.20
Price/book (mrq)2.38
Enterprise value/revenue 3.85
Enterprise value/EBITDA 14.37

Trading information

Stock price history

Beta (5Y monthly) 0.69
52-week change 3-5.26%
S&P500 52-week change 326.49%
52-week high 3170.98
52-week low 3135.80
50-day moving average 3154.45
200-day moving average 3152.06

Share statistics

Avg vol (3-month) 346
Avg vol (10-day) 310
Shares outstanding 5129.24M
Implied shares outstanding 6473.66M
Float 8128.91M
% held by insiders 10.06%
% held by institutions 157.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.2
Forward annual dividend yield 41.43%
Trailing annual dividend rate 32.20
Trailing annual dividend yield 31.43%
5-year average dividend yield 41.24
Payout ratio 435.14%
Dividend date 3N/A
Ex-dividend date 429 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 13.07%
Operating margin (ttm)18.18%

Management effectiveness

Return on assets (ttm)4.57%
Return on equity (ttm)10.07%

Income statement

Revenue (ttm)20.82B
Revenue per share (ttm)47.92
Quarterly revenue growth (yoy)-3.30%
Gross profit (ttm)N/A
EBITDA 5.12B
Net income avi to common (ttm)2.72B
Diluted EPS (ttm)6.26
Quarterly earnings growth (yoy)-12.80%

Balance sheet

Total cash (mrq)3.16B
Total cash per share (mrq)7.29
Total debt (mrq)9.95B
Total debt/equity (mrq)35.46%
Current ratio (mrq)1.29
Book value per share (mrq)64.54

Cash flow statement

Operating cash flow (ttm)3.97B
Levered free cash flow (ttm)3.16B